Finance

Lists
Why is NSRX down 2,77%?
Dive Deeper
NSRX:NYSEAMERICAN
Nasus Pharma Ltd
US$3,51
-2,77%
(-0,100) 1D
US$3,63
+3,42% (+0,12)
After hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSRX...
Open
US$3,63
High
US$3,66
Low
US$3,44
Mkt. cap
41,12 ລ້ານ
Avg. vol.
17,89 ພັນ
Volume
16,92 ພັນ
52-wk high
US$9,50
52-wk low
US$1,98
EPS
US$-1,13
Shares outstanding
11,71 ລ້ານ
No. of employees
7
Open
US$3,63
High
US$3,66
Low
US$3,44
Mkt. cap
41,12 ລ້ານ
Avg. vol.
17,89 ພັນ
Volume
16,92 ພັນ
52-wk high
US$9,50
52-wk low
US$1,98
EPS
US$-1,13
Shares outstanding
11,71 ລ້ານ
No. of employees
7
News stories
From web sources and news partners
About Nasus Pharma Ltd
CEO-
Employees7
Founded2019
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
1,29 ລ້ານ
1,29 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
1,73 ລ້ານ
1,73 ລ້ານ
Operating expense
-
-
3,02 ລ້ານ
3,02 ລ້ານ
Total operating expenses
-
-
3,02 ລ້ານ
3,02 ລ້ານ
Operating income
-
-
-3,02 ລ້ານ
-3,02 ລ້ານ
Other non operating income
-
-
-17,50 ພັນ
-17,50 ພັນ
EBT including unusual items
-
-
-2,97 ລ້ານ
-2,97 ລ້ານ
EBT excluding unusual items
-
-
-2,97 ລ້ານ
-2,97 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-2,97 ລ້ານ
-2,97 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
64,00 ພັນ
64,00 ພັນ
Interest expense
-
-
-
-
Net interest expenses
-
-
64,00 ພັນ
64,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google